Powered By Bing

Snyder Lab: Publications

2018

  • Davis JC, Daw NC, Navid F, Billups CA, Wu J, Bahrami A, Jenkins JJ, Snyder SE, Reddick WE, Santana VM, McCarville E, Guo J, Shulkin BL. FDG Uptake During Early Adjuvant Chemotherapy Predicts Histologic Response in Pediatric and Young Adult Patients with Osteosarcoma. J Nucl Med, 59:25-30, 2018. PMID:28611244

  • Kwizera EA, O’Connor R, Vinduska V, Williams M, Butch ER, Snyder SE, Chen X, Huang X. Molecular Detection and Analysis of Exosomes Using Surface-Enhanced Raman Scattering Gold Nanorods and a Miniaturized Device. Theranostics, 8:2722-36, 2018.


2017

  • Kaste SC, Snyder SE, Metzger ML, Sandlund JT, Howard SC, Krasin M, Shulkin BL. Comparison of 11C-methionine and 18F-FDG PET-CT for staging and follow-up of pediatric lymphoma. J Nucl Med, 58:419-424, 2017. PMID:27609791

  • Lucas JT, Serrano N, Kim H, Li X, Snyder SE, Hwang S, Li Y, Hua C-H, Broniscer A, Merchant TE, Shulkin BL. 11C-Methionine positron emission tomography delineates non-contrast enhancing tumor regions at high risk for recurrence in pediatric high-grade glioma. J Neuro-Onc, 132(1):163-170, 2017. PMID:28078638

  • Linstad EJ, Vāvere AL, Hu B, Kempinger JJ, Snyder SE, DiMagno SG. Thermolysis and Radiofluorination of Diaryliodonium Salts Derived from Anilines. Org Biomol Chem, 15:2246-2252, 2017. PMID: 28230886


2016

  • Neumann KD, Qin L, Vavere AL, Shen B, Miao Z, Chin FT, Snyder SE, DiMagno SG. Efficient automated synthesis of high specific activity 6-[18F]fluorodopamine using a diaryliodonium salt precursor. J Labelled
    Compd Radiopharm, 59:30-34, 2016. PMC4715522.

  • Jiao P, Otto M, Geng Q, Li C, Li F, Butch ER, Snyder SE, Zhou H, Yan B. Enhancing both CT imaging and natural killer cell-mediated cancer cell killing by a GD2-targeting nanoconstruct. J Materials Chem B, 4:513-520,
    2016. PMC4830492


2015

  • Ostermeier A, McCarville MB, Navid F, Snyder SE, Shulkin BL. FDG PET/CT imaging of desmoplastic smallround cell tumor: Findings as staging, during treatment and at follow up. Ped Radiol, 45(9):1308-1315, 2015.PMC4529370.

  • Hu* B, Vavere* AL, Neumann KD, DiMagno S, Snyder SE. A practical, automated synthesis of meta-[18F]fluorobenzylguanidine for clinical use. ACS Chem Neurosci, 6(11):1870-1879, 2015. PMC4651823.


2014

  • Stewart E, Goshorn R, Bradley C, Griffiths LM, Benavente C, Twarog NR, Miller GM, Caufield W, Freeman BB 3rd, Bahrami A, Pappo A, Wu J, Loh A, Karlström Å, Calabrese C, Gordon B, Tsurkan L, Hatfield MJ, Potter PM, Snyder SE, Thiagarajan S, Shirinifard A, Sablauer A, Shelat AA, Dyer MA. Targeting the DNA repair pathway in Ewing sarcoma. Cell Reports, 9(3):829-841, 2014. PMC4386669.


2013

  • Laser BS, Merchant TE, Indelicato DJ, Hua C-H, Shulkin BL, Snyder SE. Evaluation of children with craniopharyngioma using carbon-11 methionine PET prior to proton therapy. Neuro-Oncology, 15(4):506-510, 2013. PMC3607263

  • Harris SM, Davis JC, Snyder SE, Butch ER, Vāvere AL, Kocak M, Shulkin BL. Evaluation of the Biodistribution of [11C]Methionine in Children and Young Adults. J Nucl Med, 54:1902-1908, 2013. PMC3924715.


2012

  • Vavere AL, Butch ER, Dearling JL, Packard, AB, Navid F, Shulkin BL, Barfield RC,Snyder SE. 64Cu-p-NH2-Bn-DOTA-hu14.18K322A, a PET radiotracer targeting neuroblastoma and melanoma. J Nucl Med 53(11):1772-1778, 2012.

  • Vavere AL,*Snyder SE.Synthesis of L-[methyl-11C]methionine (11C-MET). In: Radiochemical Synthese, Scott PJ and Hockley B, eds. New York: John Wiley & Sons, pp 199-212, 2012.


2011

  • Gao N, Zhang Q, Mu Q, Bai Y, Li L, Zhou H, Butch ER, Powell TB,Snyder SE, Jiang G, Yan B. Steering carbon nanotubes to scavenger receptor recognition by nanotube surface chemistry modification partially alleviates NFκB activation and reduces its immunotoxicity. ACS Nano 5:4581-4591, 2011.

  • Jiao P, Zhou H, Otto M, Mu Q, Li L, Su G, Zhang Y, Butch E, Snyder S, Jiang G, Yan B. Leading neuroblastoma cells to die by multiple premeditated attacks from a multifunctionalized nanoconstruct. J Am Chem Soc 133:13918-21, 2011.


2010

  • Bai Y, Zhang Y, Zhang J, Mu Q, Zhang W, Butch ER, Snyder SE, Yan B. Repeated carbon nanotube administrations in male mice cause reversible testis damage without affecting fertility. Nature Nanotechnology (in press), 2010.

  • Loveless VS, Surdock CP, Bhattacharjee H. Evaluation of Zeta-Potential and Particle Size of Technetium99mTc-Sulfur Colloid Subsequent to the Addition of Lidocaine and Sodium Bicarbonate. Journal of Nuclear Medicine Technology 38(1): 49-52, 2010.

  • Sorkin LS, Otto M, Baldwin WM 3rd, Vail E, Gillies SD, Handgretinger R, Barfield RC, Ming Yu H, Yu AL. Anti-GD(2) with an FC point mutation reduces complement fixation and decreases antibody-induced allodynia. Pain 149(1): 135-42, 2010.


2009

  • Vāvere AL, Biddlecombe GB, Spees WM, Garbow JR, Wijesinghe D, Andreev OA, Engelman DM, Reshetnyak YK, Lewis JS. A Novel Technology for the Imaging of Acidic Prostate Tumors by Positron Emission Tomography. Cancer Research 69: 4510-4516, 2009.

  • Kilbourn MR, Butch ER, Desmond T, Sherman P, Harris PE, Frey KA. In vivo [11C]dihydrotetrabenazine binding in rat striatum: sensitivity to dopamine concentrations. Nuclear Medicine & Biology 7(1): 3-8, 2009.


2008

  • Li X, Jung YW, Snyder SE, Blair J, Sherman PS, Desmond T, Frey KA, Kilbourn MR. 5-tert-Butyl-2-(4'-[18F]fluoropropynylphenyl)-1,3-dithiane oxides: potential new GABAAreceptor radioligands. Nuclear Medicine & Biology 35(5): 549-59, 2008.

  • Gomez V, Gispert JD, Amador V, Llop J. New method for routine production of L-[methyl-11C]methionine: in loop synthesis. Journal of Labelled Compounds & Radiopharmaceuticals 51(1): 83-86, 2008.

  • Bonnitcha PD, Vāvere AL, Lewis JS, Dilworth JR. In Vitro and In Vivo Evaluation of Bifunctional Bisthiosemicarbasone64Cu-Complexes for the Positron Emission Tomography Imaging of Hypoxia. Journal of Medicinal Chemistry 51: 2985-2991, 2008.

  • Vāvere AL, Lewis JS. Examining the Relationship Between Cu-ATSM Hypoxia Selectivity and Fatty Acid Synthase Expression in Human Prostate Cancer Cell Lines. Nuclear Medicine and Biology 35: 273-279, 2008.

  • Vāvere AL, Kridel SJ, Wheeler FB, Lewis JS. 1-11C-Acetate as a PET Radiopharmaceutical for Imaging Fatty Acid Synthase Expression in Prostate Cancer.Journal of Nuclear Medicine 49(2): 327-334, 2008.


2007

  • Kilbourn MR, Ma B, Butch ER, Quesada C, Sherman PS. Anesthesia increases in vivoN-([18F]fluoroethyl)piperidinyl benzilate binding to the muscarinic cholinergic receptor. Nuclear Medicine & Biology 34(5): 479-82, 2007.

  • Wei L, Butcher C, Miao Y, Gallazzi F, Quinn TP, Welch MJ, Vāvere AL, Lewis JS. Ga-68 labeled DOTA-Rhenium Cyclized a-MSH Analog for Imaging of Malignant Melanoma. Nuclear Medicine & Biology 34: 945-953, 2007.

  • Vāvere AL, Lewis JS. Cu-ATSM for the PET Imaging of Hypoxia. Dalton Transactions (43): 4893-4902, 2007.

  • Otto M, Chen X, Martin WJ, Leung W, Knowles J, Holladay M, Houston J, Handgretinger R, Barfield RC. Selection of stem cells by using antibodies that target different CD34 epitopes yields different patterns of T-cell differentiation. Stem Cells 25(2): 537-42, 2007.

  • Barfield R, Chen X, Otto M, Handgretinger R. Beyond the FACS. Stem Cells 25(11): 2972, 2007.


2006

  • Kuhl DE, Koeppe RA, Snyder SE, Minoshima S, Frey KA, Kilbourn MR. Imaging butyrulcholinesterase activity in Alzheimer's disease. Annals of Neurology 60(6): 746, 2006.

  • Kuhl DE, Koeppe RA, Snyder SE, Minoshima S, Frey KA, Kilbourn MR. In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses. Annals of Neurology 59(1):13-20, 2006.


2005

  • Shao X, Koeppe RA, Butch ER, Kilbourn MR, Snyder SE. Evaluation of18F-labeled acetylcholinesterase substrates as PET radiotracers. Bioorganic & Medicinal Chemistry 13(3): 869-75, 2005.

  • Vāvere AL, Welch MJ. Preparation, Biodistribution and MicroPET Imaging of Titanium-45-Transferrin. Journal of Nuclear Medicine 46(4): 683-690, 2005.

  • Vāvere AL, Laforest R, Welch MJ. Production, Preparation and MicroPET Imaging of Titanium-45. Nuclear Medicine & Biology 32(2): 117-122, 2005.

  • Otto M, Barfield RC, Martin WJ, Iyengar R, Leung W, Leimig T, Chaleff S, Gillies SD, Handgretinger R. Combination immunotherapy with clinical-scale enriched human gammadelta T cells, hu14.18 antibody, and the immunocytokine Fc-IL7 in disseminated neuroblastoma. Clinical Cancer Research 11(23): 8486-91, 2005.

  • Otto M, Barfield RC, Iyengar R, Gatewood J, Müller I, Holladay MS, Houston J, Leung W, Handgretinger R. Human gammadelta T cells from G-CSF-mobilized donors retain strong tumoricidal activity and produce immunomodulatory cytokines after clinical-scale isolation. Journal of Immunotherapy 28(1): 73-8, 2005.

  • Chen X, Barfield R, Benaim E, Leung W, Knowles J, Lawrence D, Otto M, Shurtleff SA, Neale GA, Behm FG, Turner V, Handgretinger R. Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogenic hematopoietic stem cell transplantation in pediatric patients. Blood 105(2): 886-93, 2005.